Quest says FDA cleared new ‘lab method’ that will cut coronavirus testing delays
A Quest Diagnostics Inc. requisition form is displayed for a photograph at Perry Memorial Hospital in Princeton, Illinois, U.S., on Wednesday, Oct. 11, 2017.
Daniel Acker | Bloomberg | Getty Images
Coronavirus test manufacturer Quest Diagnostics announced Wednesday that the Food and Drug Administration has granted the company emergency authorization to use a new technique it says will cut the testing turnaround time to two to three days for most people.
Commercial testing laboratories like Quest and rival LabCorp have struggled to keep pace with testing as Covid-19 outbreaks spread across the American South and West. Public health specialists have stressed that the current testing delays render the tests essentially worthless because it takes so long to get results that by the time people find out they have the virus, they may have already passed it along to others.
[Source: CNBC News]